Status:
NOT_YET_RECRUITING
Concurrent Surgery for Prolapse and Stress Urinary Incontinence to Reduce Further Surgery for Incontinence
Lead Sponsor:
Shalamar Institute of Health Sciences
Conditions:
Stress Urinary Incontinence
Eligibility:
FEMALE
41-83 years
Phase:
NA
Brief Summary
Urinary incontinence is a common and distressing medical condition which affects 26% of women in developing countries.Globally upto 54% women suffer from pelvic organ prolapse and stress urinary incon...
Detailed Description
INTRODUCTION Urinary incontinence (UI), is a common and distressing medical condition which affects 26% of women in developing countries and stress urinary incontinence (SUI) (12.6%) is the most comm...
Eligibility Criteria
Inclusion
- Adult females 41-83 years age presenting with concurrent prolapse and stress urinary incontinence willing to participate in the study.
Exclusion
- \- Exclusion criteria: Study exclusion criteria will be urge incontinence according to questionnaire, urinary tract infection, unwilling for surgery, unfit for surgery, urogenital malignancy, urolithiasis.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06521450
Start Date
October 1 2024
End Date
March 1 2025
Last Update
July 26 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.